Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 232 of 232 entries
Sorted by: Best Match Show Resources per page
Treatment Preferences for Cardiac Procedures of Patients With Chronic Kidney Disease in Acute Coronary Syndrome: Design and Pilot Testing of a Discrete Choice Experiment.

Canadian journal of kidney health and disease

Wilson T, Javaheri P, Finlay J, Hazlewood G, Wilton SB, Sajobi T, Levin A, Pearson W, Connolly C, James MT.
PMID: 33552527
Can J Kidney Health Dis. 2021 Jan 27;8:2054358120985375. doi: 10.1177/2054358120985375. eCollection 2021.

BACKGROUND: Chronic kidney disease is associated with a high incidence of acute coronary syndrome and related morbidity and mortality. Treatment choices for patients with chronic kidney disease involve trade-offs in the potential benefits and harms of invasive management options.OBJECTIVE:...

Cite
Wilson T, Javaheri P, Finlay J, et al. Treatment Preferences for Cardiac Procedures of Patients With Chronic Kidney Disease in Acute Coronary Syndrome: Design and Pilot Testing of a Discrete Choice Experiment. Can J Kidney Health Dis. 2021;8:2054358120985375doi: 10.1177/2054358120985375.
Wilson, T., Javaheri, P., Finlay, J., Hazlewood, G., Wilton, S. B., Sajobi, T., Levin, A., Pearson, W., Connolly, C., & James, M. T. (2021). Treatment Preferences for Cardiac Procedures of Patients With Chronic Kidney Disease in Acute Coronary Syndrome: Design and Pilot Testing of a Discrete Choice Experiment. Canadian journal of kidney health and disease, 82054358120985375. https://doi.org/10.1177/2054358120985375
Wilson, T, et al. "Treatment Preferences for Cardiac Procedures of Patients With Chronic Kidney Disease in Acute Coronary Syndrome: Design and Pilot Testing of a Discrete Choice Experiment." Canadian journal of kidney health and disease vol. 8 (2021): 2054358120985375. doi: https://doi.org/10.1177/2054358120985375
Wilson T, Javaheri P, Finlay J, Hazlewood G, Wilton SB, Sajobi T, Levin A, Pearson W, Connolly C, James MT. Treatment Preferences for Cardiac Procedures of Patients With Chronic Kidney Disease in Acute Coronary Syndrome: Design and Pilot Testing of a Discrete Choice Experiment. Can J Kidney Health Dis. 2021 Jan 27;8:2054358120985375. doi: 10.1177/2054358120985375. eCollection 2021. PMID: 33552527; PMCID: PMC7844446.
Copy Download .nbib Format: NLM
Segmental arterial mediolysis: a rare cause of abdominal pain masquerading as vasculitis.

Rheumatology (Oxford, England)

Connolly CM, Yu A, Seo P, Paik JJ.
PMID: 33788907
Rheumatology (Oxford). 2021 Oct 02;60(10):e354-e355. doi: 10.1093/rheumatology/keab326.

No abstract available.

Cite
Connolly CM, Yu A, Seo P, et al. Segmental arterial mediolysis: a rare cause of abdominal pain masquerading as vasculitis. Rheumatology (Oxford). 2021;60(10):e354-e355doi: 10.1093/rheumatology/keab326.
Connolly, C. M., Yu, A., Seo, P., & Paik, J. J. (2021). Segmental arterial mediolysis: a rare cause of abdominal pain masquerading as vasculitis. Rheumatology (Oxford, England), 60(10), e354-e355. https://doi.org/10.1093/rheumatology/keab326
Connolly, Caoilfhionn M, et al. "Segmental arterial mediolysis: a rare cause of abdominal pain masquerading as vasculitis." Rheumatology (Oxford, England) vol. 60,10 (2021): e354-e355. doi: https://doi.org/10.1093/rheumatology/keab326
Connolly CM, Yu A, Seo P, Paik JJ. Segmental arterial mediolysis: a rare cause of abdominal pain masquerading as vasculitis. Rheumatology (Oxford). 2021 Oct 02;60(10):e354-e355. doi: 10.1093/rheumatology/keab326. PMID: 33788907; PMCID: PMC8487304.
Copy Download .nbib Format: NLM
Systemic sclerosis (scleroderma): remaining challenges.

Annals of translational medicine

Connolly MK.
PMID: 33842659
Ann Transl Med. 2021 Mar;9(5):438. doi: 10.21037/atm-20-5449.

Despite progress in treating internal organ involvement in systemic sclerosis (scleroderma) (SSc), such as pulmonary disease, effective treatments for the hallmark of the disease, cutaneous fibrosis, remain elusive. None of the disease-modifying antirheumatic drugs (DMARDS) have shown proven efficacy...

Cite
Connolly MK. Systemic sclerosis (scleroderma): remaining challenges. Ann Transl Med. 2021;9(5):438doi: 10.21037/atm-20-5449.
Connolly, M. K. (2021). Systemic sclerosis (scleroderma): remaining challenges. Annals of translational medicine, 9(5), 438. https://doi.org/10.21037/atm-20-5449
Connolly, Mary Karin. "Systemic sclerosis (scleroderma): remaining challenges." Annals of translational medicine vol. 9,5 (2021): 438. doi: https://doi.org/10.21037/atm-20-5449
Connolly MK. Systemic sclerosis (scleroderma): remaining challenges. Ann Transl Med. 2021 Mar;9(5):438. doi: 10.21037/atm-20-5449. PMID: 33842659; PMCID: PMC8033370.
Copy Download .nbib Format: NLM
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.

Annals of the rheumatic diseases

Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ.
PMID: 33757968
Ann Rheum Dis. 2021 Mar 23; doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.

No abstract available.

Cite
Boyarsky BJ, Ruddy JA, Connolly CM, et al. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021;doi: 10.1136/annrheumdis-2021-220289.
Boyarsky, B. J., Ruddy, J. A., Connolly, C. M., Ou, M. T., Werbel, W. A., Garonzik-Wang, J. M., Segev, D. L., & Paik, J. J. (2021). Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2021-220289
Boyarsky, Brian J, et al. "Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases." Annals of the rheumatic diseases vol. (2021). doi: https://doi.org/10.1136/annrheumdis-2021-220289
Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Mar 23; doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23. PMID: 33757968.
Copy Download .nbib Format: NLM
Showing 229 to 232 of 232 entries